Linee guida sulla steatosi epatica non alcolica (NAFLD)

L’American Association for the Study of Liver Diseases (AASLD) ha pubblicato una guida di pratica clinica sulla steatosi epatica non alcolica. Questo nuovo documento fornisce dichiarazioni piuttosto che raccomandazioni formali. Sono evidenziati dei punti chiave e dei concetti importanti e rilevanti per comprendere la malattia e la sua gestione.

Scarica e leggi il full text dell’articolo:

• AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease.
  Rinella, Mary E.; Neuschwander-Tetri, Brent A.; Siddiqui, Mohammad Shadab; Abdelmalek, Manal F.; Caldwell, Stephen; Barb, Diana; Kleiner, David E.; Loomba, Rohit.
  Hepatology ():10.1097/HEP.0000000000000323, February 3, 2023. | DOI: 10.1097/HEP.0000000000000323

Documenti correlati:

• Management of NAFLD in primary care settings – Liver International
• Non-alcoholic fatty liver disease: A patient guideline – JHEP Reports
• Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease – Gastroenterology
• Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association – Arteriosclerosis, Thrombosis, and Vascular Biology
• AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review – Gastroenterology